Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. - Wikidata - awgldk - TriplyDB

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

http://www.wikidata.org/entity/Q37288603

about

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

http://www.wikidata.org/entity/Q37288603

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@en

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@nl

type

label

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@en

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@nl

prefLabel

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@en

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@nl

P1433

Q37288603-D219EA33-200C-4130-913A-548C50CF4BD2

P1476

Q37288603-2D8EC840-58BB-46D7-9E5C-370EE7447ECE

P2093

Q37288603-16F97FB0-0570-4266-AFEB-9D656BB32198

Q37288603-18576B32-7592-40C5-9981-0F21A303FB22

Q37288603-3AD38C47-D1CB-4C6B-B6E7-EE6F33EAA890

Q37288603-977D8AB3-C4C7-4F34-9D32-65D6DBFB36D2

Q37288603-E99CF09C-F9DA-4BD6-AA29-808470677B43

P2860

Q37288603-0469A103-F3BD-45AC-9AA7-5E058D7DFA63

Q37288603-2F3BC96A-F0D0-4D88-94B2-ED3E5C83A4ED

Q37288603-45F7D115-1623-4217-98FE-BA3A7E10AB9F

Q37288603-495EE95C-C563-4403-99D5-5E00A5DDC482

Q37288603-6A5E9772-9BD1-4AD5-9078-B000EDB7C87C

Q37288603-72DFDA22-89D5-4F84-8F65-4077A97D6EDE

Q37288603-7A99DBF8-1194-4954-B237-9A79486BE33E

Q37288603-80111D28-ECA7-4BAD-A65C-6CF4DC531612

Q37288603-81ADA9EA-7A34-4D38-AD3B-9CF1381FD952

Q37288603-86C13727-BB5A-44FF-970C-0B9D4108AC72

P304

Q37288603-2556ACAC-16C6-42A5-88CD-881F87984677

P31

Q37288603-D178720F-4305-4444-8C74-AF29AFAC697D

P356

Q37288603-1720915E-FB6E-462B-A4EE-423E67291766

P433

Q37288603-2A59B2E5-344C-495C-81FE-EC50B5A0C14A

P478

Q37288603-9AEAD39A-FD3B-40CA-B91B-D5DB59506085

P577

Q37288603-FFD078F0-E1FC-414E-8960-4C89D6D53837

P698

Q37288603-0E4E10C1-DD94-40DB-9EF3-FF18733F8A3E

P932

Q37288603-C2C0CA6B-03C7-4104-BBA4-211BCCB1CCDB

P356

P1433

Oncology Letters

P1476

Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report.

@en

P2093

Alba Hernández-García

http://www.w3.org/2001/XMLSchema#string

Isabel Pajares-Bernard

http://www.w3.org/2001/XMLSchema#string

Javier Martínez-Trufero

http://www.w3.org/2001/XMLSchema#string

Jorge Hernando-Cubero

http://www.w3.org/2001/XMLSchema#string

Pilar Sanz-Moncasi

http://www.w3.org/2001/XMLSchema#string

P2860

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma.

Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth

Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma.

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.

P304

2936-2941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4950

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698882

http://www.w3.org/2001/XMLSchema#string

P932

5038563

http://www.w3.org/2001/XMLSchema#string